I have an article up at Seeking Alpha on adding value in the cannabis space.
FSD Pharma (C.HUGE) understood from the beginning that just growing cannabis for the Canadian recreational market was a relatively low margin business and that, over time, those margins would shrink.
While HUGE will certainly capitalize on opportunities in the recreational market, its real focus is on the pharmacological potential of cannabis.